Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick J Raal

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|November 6, 2012
Lomitapide for homozygous familial hypercholesterolaemiaFrederick J Raal
Metabolic Syndrome and Related Disorders|April 30, 2009
Pathogenesis and management of the dyslipidemia of the metabolic syndromeFrederick J Raal
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia: The Future Looks Brighter But Not for AllFrederick J Raal
The Lancet. Global Health|February 18, 2022
Statins: are they appropriate for all patients?Frederick J Raal, Farzahna Mohamed
The New England Journal of Medicine|May 5, 2021
Hyperpigmentation from Addison's DiseaseFarzahna Mohamed, Frederick J Raal
Current Opinion in Lipidology|March 10, 2025
Familial hypercholesterolemia in pregnancyFahad Alnouri, Frederick J Raal
The Lancet. Diabetes & Endocrinology|July 6, 2019
More aggressive lipid lowering in people with diabetes?Frederick J Raal, Farzahna Mohamed
Nature Reviews. Cardiology|March 11, 2026
ANGPTL3-lowering strategies to address residual cardiovascular riskFarzahna Mohamed, Frederick J Raal
Lancet (London, England)|November 13, 2020
Never too old to benefit from lipid-lowering treatmentFrederick J Raal, Farzahna Mohamed
Clinical Chemistry|April 28, 2023
Severe Hypophosphatemia: The Hidden TruthFarzahna Mohamed, Frederick J Raal
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|November 6, 2012
Lomitapide for homozygous familial hypercholesterolaemiaFrederick J Raal
Metabolic Syndrome and Related Disorders|April 30, 2009
Pathogenesis and management of the dyslipidemia of the metabolic syndromeFrederick J Raal
JACC. Advances|June 28, 2024
Homozygous Familial Hypercholesterolemia: The Future Looks Brighter But Not for AllFrederick J Raal
The Lancet. Global Health|February 18, 2022
Statins: are they appropriate for all patients?Frederick J Raal, Farzahna Mohamed
The New England Journal of Medicine|May 5, 2021
Hyperpigmentation from Addison's DiseaseFarzahna Mohamed, Frederick J Raal
Current Opinion in Lipidology|March 10, 2025
Familial hypercholesterolemia in pregnancyFahad Alnouri, Frederick J Raal
The Lancet. Diabetes & Endocrinology|July 6, 2019
More aggressive lipid lowering in people with diabetes?Frederick J Raal, Farzahna Mohamed
Nature Reviews. Cardiology|March 11, 2026
ANGPTL3-lowering strategies to address residual cardiovascular riskFarzahna Mohamed, Frederick J Raal
Lancet (London, England)|November 13, 2020
Never too old to benefit from lipid-lowering treatmentFrederick J Raal, Farzahna Mohamed
Clinical Chemistry|April 28, 2023
Severe Hypophosphatemia: The Hidden TruthFarzahna Mohamed, Frederick J Raal
Pageof 19